Your browser doesn't support javascript.
Bioinformatics and immunoinformatics to support COVID-19 vaccine development.
Ishack, Stephanie; Lipner, Shari R.
  • Ishack S; New York University School of Medicine, New York, New York, USA.
  • Lipner SR; Department of Dermatology, Weill Cornell Medicine, New York, New York, USA.
J Med Virol ; 93(9): 5209-5211, 2021 Sep.
Article in English | MEDLINE | ID: covidwho-1182167
ABSTRACT
Severe acute respiratory syndrome coronavirus 2 has infected over 109 000 000 people with 2 423 443 deaths as of February 17, 2021. Currently, there are no approved or consistently effective treatments, and conventional vaccines may take several years for development and testing. In silico methods of bioinformatics, vaccinogenomics, immunoinformatics, structural biology, and molecular simulations can be used for more rapid and precise vaccine design. This paper highlights two major immunoinformatics strategies that are used in designing novel and effective vaccines and therapeutics reverse vaccinology and structural vaccinology.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Computational Biology / Vaccinology / COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Med Virol Year: 2021 Document Type: Article Affiliation country: Jmv.27017

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Computational Biology / Vaccinology / COVID-19 Vaccines / COVID-19 Topics: Vaccines Limits: Humans Language: English Journal: J Med Virol Year: 2021 Document Type: Article Affiliation country: Jmv.27017